The Lessons of Asilomar for Today’s Science
By Alexander Capron,
The New York Times
| 05. 28. 2015
Untitled Document
There is a precedent for establishing internationally agreed-upon limits for new science, though it can be hard to do.
In 1973, scientists who were using novel molecular techniques to splice DNA between different organisms asked the National Academy of Sciences to consider the potential hazards as they might affect the public. In July 1974, an Academy-appointed committee publicly called for a large category of experiments to be suspended until leaders in the field could plan a way forward. Such a self-imposed moratorium on basic research was unprecedented, but it worked.
A hundred and fifty scientists and physicians from around the world gathered in February 1975 at the Asilomar conference center near Monterey, California, in what one scientist termed an amazing show of “self denial and social responsibility in the face of strong intellectual temptation” to continue the experiments.
The outcome of the meeting was equally impressive. Categories of experiments were graded by their riskiness: Some were deemed excessively dangerous and kept off-limits, while others were to be allowed once the appropriate biological and physical means of risk-containment had...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...